Your browser doesn't support javascript.
loading
Long Non-Coding RNAs Associated with Heterochromatin Function in Immune Cells in Psychosis.
Sudhalkar, Niyati; Rosen, Cherise; Melbourne, Jennifer K; Park, Mi Rae; Chase, Kayla A; Sharma, Rajiv P.
Afiliación
  • Sudhalkar N; Department of Psychiatry. University of Illinois at Chicago, Chicago, IL 60612, USA. nsudha2@uic.edu.
  • Rosen C; Department of Psychiatry. University of Illinois at Chicago, Chicago, IL 60612, USA. ccrosen@uic.edu.
  • Melbourne JK; Department of Psychiatry. University of Illinois at Chicago, Chicago, IL 60612, USA. jennikm@uic.edu.
  • Park MR; Department of Psychiatry. University of Illinois at Chicago, Chicago, IL 60612, USA. mpark81@uic.edu.
  • Chase KA; Department of Psychiatry. University of Illinois at Chicago, Chicago, IL 60612, USA. kchase1@uic.edu.
  • Sharma RP; Department of Mental Health, Jesse Brown VA Medical Center, Chicago, IL 60612, USA. kchase1@uic.edu.
Noncoding RNA ; 4(4)2018 Dec 18.
Article en En | MEDLINE | ID: mdl-30567388
Psychosis is associated with chronic immune dysregulation. Many long non-coding RNAs (lncRNAs) display abnormal expression during activation of immune responses, and play a role in heterochromatic regulation of gene promoters. We have measured lncRNAs MEG3, PINT and GAS5, selected for their previously described association with heterochromatin. Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples collected from 86 participants with a diagnosis of psychosis and 44 control participants. Expression was assessed in relation to diagnosis, illness acuity status, and treatment with antipsychotic medication. We observed diagnostic differences with MEG3, PINT and GAS5, and symptom acuity effect with MEG3 and GAS5. Medication effects were evident in those currently on treatment with antipsychotics when compared to drug-naïve participants. We observed that clinical diagnosis and symptom acuity predict selected lncRNA expression. Particular noteworthy is the differential expression of MEG3 in drug naïve participants compared to those treated with risperidone. Additionally, an in vitro cell model using M2tol macrophages was used to test the effects of the antipsychotic drug risperidone on the expression of these lncRNAs using quantitative real-time PCR (qRT-PCR). Significant but differential effects of risperidone were observed in M2tol macrophages indicating a clear ability of antipsychotic medications to modify lncRNA expression.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Noncoding RNA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Noncoding RNA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza